(Q39076760)

8 September 2017

title

Activation of cyclic AMP/PKA pathway inhibits bladder cancer cell invasion by targeting MAP4-dependent microtubule dynamics (English)

1 reference

8 September 2017

1 reference

7

1 reference

8 September 2017

Yanqiu Ou

1

1 reference

8 September 2017

Xiaoke Zheng

2

1 reference

8 September 2017

Yixing Gao

3

1 reference

8 September 2017

Minfeng Shu

4

1 reference

8 September 2017

Tiandong Leng

5

1 reference

8 September 2017

Yan Li

6

1 reference

8 September 2017

Wenbo Zhu

8

1 reference

8 September 2017

Yijun Huang

9

1 reference

8 September 2017

Yuxi Zhou

10

1 reference

8 September 2017

Jianjun Tang

11

1 reference

8 September 2017

Pengxin Qiu

12

1 reference

8 September 2017

Guangmei Yan

13

1 reference

8 September 2017

Jun Hu

14

1 reference

8 September 2017

Huaizhen Ruan

15

1 reference

8 September 2017

Haiyan Hu

16

1 reference

8 September 2017

publication date

17 October 2013

1 reference

8 September 2017

1 reference

8 September 2017

volume

32

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

47.e21-8

1 reference

Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

7 January 2021

Focus on bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

R-253 disrupts microtubule networks in multiple tumor cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

The MAP2/Tau family of microtubule-associated proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Mammalian septins regulate microtubule stability through interaction with the microtubule-binding protein MAP4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Microtubule alterations and mutations induced by desoxyepothilone B: implications for drug-target interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Accompanying protein alterations in malignant cells with a microtubule-polymerizing drug-resistance phenotype and a primary resistance mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Regulation of microtubule dynamics by extracellular signals: cAMP-dependent protein kinase switches off the activity of oncoprotein 18 in intact cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Phosphorylation of microtubule-associated proteins MAP2 and MAP4 by the protein kinase p110mark. Phosphorylation sites and regulation of microtubule dynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Transcriptional and post-transcriptional down-regulation of cyclin D1 contributes to C6 glioma cell differentiation induced by forskolin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

A Ras inhibitor tilts the balance between Rac and Rho and blocks phosphatidylinositol 3-kinase-dependent glioblastoma cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

The 2004 WHO classification of bladder tumors: a summary and commentary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Urothelial tumorigenesis: a tale of divergent pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Regulation of actin-based cell migration by cAMP/PKA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Elevation of intracellular cAMP inhibits growth factor-mediated matrix metalloproteinase-9 induction and keratinocyte migration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Microtubule destabilization by cdc2/H1 histone kinase: Phosphorylation of a “Pro-rich region” in the microtubule-binding domain of MAP-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2013.06.017

10.1016/J.UROLONC.2013.06.017

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference